IPO

Jessica Schaefer's new firm leases a lavish SoHo 'clubhouse,' betting millions on the city's AI boom and a new model for high-stakes communications.

Prop trading firm Topstep partners with skier Alex Ferreira for a major rebrand, a new ad campaign, and an expanded ecosystem for retail traders.

With a new CRO from Zoom, LastPass aims to accelerate its B2B strategy, targeting the complex security challenges of the modern SaaS and AI-driven enterprise.

With a new CEO and stunning clinical data, BOOST Pharma advances a potential game-changer for children with the rare genetic disorder Osteogenesis Imperfecta.

A new exchange launches hourly financial tools to help energy players manage ERCOT's extreme price volatility, promising more stability and innovation.

MultiBank Group launches a 25% client bonus and a 50% partner rebate, intensifying competition and raising key questions about trader risk and leverage.

Celebrating 30 years, Topband's journey from a local supplier to a global intelligent solutions giant mirrors China's industrial evolution.

DAHON's new LUNDEN tri-fold bikes integrate DAHON-V Tech, promising the rigidity and ride quality of a full-size bike in a compact, portable package.

Following a landmark FDA approval, IceCure Medical's long-serving CFO is exiting, placing the company at a pivotal financial crossroads for its new treatment.

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.

Belgian biotech Agomab Therapeutics secures $200 million in its Nasdaq debut, fueling its mission to develop therapies for debilitating fibrotic conditions.

As the AI coding market heats up, Cursor's strategic hire of Brian McCarthy signals a major push for enterprise dominance against rivals like GitHub Copilot.

Hagerty elevates its marketing team, hiring a new SVP from AT&T to build a 'bespoke' membership experience and deepen its bond with car enthusiasts.

The restaurant group's net income fell sharply as a legal battle over its NYC flagship intensifies, while it places a risky bet on a NJ casino license.

As Omada Health preps its 2025 results, all eyes are on whether its blend of tech, human coaching, and GLP-1 support can deliver sustainable profits.

Swvl's new healthcare mobility contract in Saudi Arabia marks a strategic shift to high-value enterprise deals. Can this move stabilize the firm?

With a promising spinal cord injury drug nearing late-stage trials, NervGen appoints interim leader Dr. Adam Rogers as permanent CEO to guide the breakthrough.

Semiconductor leader Astera Labs launches a new R&D hub in Israel, hiring top tech veterans to develop next-gen connectivity for the demanding AI era.

Backed by robust earnings and strategic acquisitions, Atmus Filtration's latest dividend signals strong financial health and a commitment to shareholder returns.

The Middle East healthcare giant posts record profits and a $163M dividend, fueled by aggressive international acquisitions and a major bet on AI technology.